Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epirubicin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT02207361
What this trial is testing

Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 120
Testing effectiveness (Phase 2)Study completedNCT02789332
What this trial is testing

Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency

Who this might be right for
Breast CancerTriple Negative Breast NeoplasmsHRpos Breast Neoplasms+1 more
GBG Forschungs GmbH 107
Testing effectiveness (Phase 2)UnknownNCT01428414
What this trial is testing

Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer

Who this might be right for
HER-2 Positive Breast Cancer
Zhimin Shao 100
Large-scale testing (Phase 3)Study completedNCT00140075
What this trial is testing

Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer

Who this might be right for
Adenocarcinoma
Pfizer 606
Testing effectiveness (Phase 2)Study completedNCT00154739
What this trial is testing

Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
National Taiwan University Hospital 86
Early research (Phase 1)Study completedNCT00322374
What this trial is testing

Phase I Combination w/ Epirubicin

Who this might be right for
Metastatic Breast Cancer
R-Pharm 42
Post-approval studies (Phase 4)UnknownNCT01849380
What this trial is testing

Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoadjuvant Therapy
Shandong University 240
Testing effectiveness (Phase 2)Looking for participantsNCT04138719
What this trial is testing

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer

Who this might be right for
Breast CancerTriple-negative Breast CancerNab-paclitaxel
Hebei Medical University Fourth Hospital 520
Large-scale testing (Phase 3)UnknownNCT04736394
What this trial is testing

Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients

Who this might be right for
Non-muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 800
Large-scale testing (Phase 3)Study completedNCT00055679
What this trial is testing

Combination Chemotherapy in Treating Women With Stage I Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 1,512
Testing effectiveness (Phase 2)Study completedNCT00248703
What this trial is testing

Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow

Who this might be right for
Breast Cancer
Oslo University Hospital 1,128
Large-scale testing (Phase 3)UnknownNCT00516425
What this trial is testing

Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
Charing Cross Hospital 1,000
Early research (Phase 1)Looking for participantsNCT06121570
What this trial is testing

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 24
Not applicableStudy completedNCT00617370
What this trial is testing

Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

Who this might be right for
Breast CancerAdenocarcinoma of the Breast
Memorial Sloan Kettering Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT00253500
What this trial is testing

Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)UnknownNCT04213898
What this trial is testing

SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Henan Cancer Hospital 39
Large-scale testing (Phase 3)Study completedNCT01204437
What this trial is testing

Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 400
Testing effectiveness (Phase 2)Ended earlyNCT01830270
What this trial is testing

Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer

Who this might be right for
Stomach NeoplasmsOesophageal Junction CancerLower Oesophagus Cancer
Centre Hospitalier Universitaire de Besancon 30
Early research (Phase 1)UnknownNCT05251766
What this trial is testing

Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer

Who this might be right for
Breast CancerChemotherapy Effect
Xuli Meng 30
Large-scale testing (Phase 3)Study completedNCT00776724
What this trial is testing

Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm

Who this might be right for
Breast CancerChemotherapy
National Taiwan University Hospital 166
Next Page